Intrinsic value of Beam Therapeutics Inc. (BEAM)
Live fair value data for Beam Therapeutics Inc. (BEAM) is currently unavailable. Please check again shortly.
Current Price: $167.00
Valuation: Undervalued
Confidence: 9.5/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Beam Therapeutics Inc. (BEAM) undervalued or overvalued?
Based on the current model output, Beam Therapeutics Inc. appears to be undervalued with a upside of 65.00%.
Fair value vs market price — Beam Therapeutics Inc. (BEAM)
Unlock premium access to view the live fair value comparison against current market price for BEAM.
Frequently Asked Questions - BEAM
How is BEAM intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for BEAM.
Is BEAM undervalued or overvalued right now?
BEAM is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for BEAM: open their intrinsic value pages.